CAM
RLAY icon

Cresset Asset Management’s Relay Therapeutics RLAY Stock Holding History

Cresset Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,495
Closed -$363K – 1827
2026
Q1 		$363K Sell
36,495
-589
-2% -$5.27K ﹤0.01% 1201
2025
Q4 		$314K Hold
37,084
– – ﹤0.01% 1277
2025
Q3 		$194K Hold
37,084
– – ﹤0.01% 1432
2025
Q2 		$128K Buy
37,084
+7,705
+26% +$22.9K ﹤0.01% 1345
2025
Q1 		$77K Buy
+29,379
New +$115K ﹤0.01% 1633

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Cresset Asset Management's RLAY Position: Q2 2026 in Review

Cresset Asset Management sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 36,495 shares — an estimated $363K sold.

Cresset Asset Management first reported a position in RLAY in Q1 2025 and held it in 5 quarters. The position peaked at $363K in Q1 2026. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Cresset Asset Management reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Cresset Asset Management sold 36,495 Relay Therapeutics shares in Q2 2026, an estimated $363K.
  • Cresset Asset Management first reported a position in Relay Therapeutics in Q1 2025 and held it in 5 quarters.
  • Cresset Asset Management's Relay Therapeutics position peaked at $363K in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.